Current
Neuro-Oncology


Volume 21 Number 9
September 2019


Home > Disciplines > Publications > Current Neuro-Oncology > Volume 21, Year 2019 > Number 9, September


CONTENTS


CENTRAL NERVOUS SYSTEM TUMORS

GLIOMAS
BRAIN STEM GLIOMAS
DIFFUSE MIDLINE GLIOMAS
HIGH-GRADE GLIOMAS
GLIOMATOSIS CEREBRI
LOW-GRADE GLIOMAS

DIFFUSE ASTROCYTIC AND OLIGODENDROGLIAL TUMORS
GLIOBLASTOMA

EMBRYONAL TUMORS
MEDULLOBLASTOMA

METASTATIC TUMORS





CENTRAL NERVOUS SYSTEM TUMORS


Devine CA, Liu KX, Ioakeim-Ioannidou M, Susko M, Poussaint TY, Huisman TAGM, Aboian M, Brown D, Zaslowe-Dude C, Rao AD, Orlina LT, Rawal B, Mueller S, Marcus KJ, Terezakis SA, Braunstein SE, Haas-Kogan DA.
Brainstem Injury in Pediatric Patients Receiving Posterior Fossa Photon Radiation.
Int J Radiat Oncol Biol Phys. 2019 Aug 28. pii: S0360-3016(19)33688-0. doi: 10.1016/j.ijrobp.2019.08.039. [Epub ahead of print]
Source . Similar articles




Eichberg DG, Di L, Shah AH, Luther EM, Richardson AM, Sarkiss CA, Ivan ME, Komotar RJ.
Brain Tumor Surgery is Safe in Octogenarians and Nonagenarians: A Single Surgeon 741 Patient Series.
World Neurosurg. 2019 Sep 7. pii: S1878-8750(19)32385-X. doi: 10.1016/j.wneu.2019.08.219. [Epub ahead of print]
Source . Similar articles




Faltermeier C, Chai T, Syed S, Lau N, Elkaim L, Ibrahim G, Wang A, Weil A, Bendel A, Fallah A, Tu A.
Survival of infants ≤24 months of age with brain tumors: A population-based study using the SEER database.
PLoS One. 2019 Sep 25;14(9):e0223051. doi: 10.1371/journal.pone.0223051. eCollection 2019.
Source . Similar articles




Fares J, Fares MY, Fares Y.
Natural killer cells in the brain tumor microenvironment: Defining a new era in neuro-oncology.
Surg Neurol Int. 2019 Mar 26;10:43. doi: 10.25259/SNI-97-2019. eCollection 2019.
Source . Similar articles



GLIOMAS


Verburg N, Koopman T, Yaqub MM, Hoekstra OS, Lammertsma AA, Barkhof F, Pouwels PJW, Reijneveld JC, Heimans JJ, Rozemuller AJM, Bruynzeel AME, Lagerwaard F, Vandertop WP, Boellaard R, Wesseling P, de Witt Hamer PC.
Improved detection of diffuse glioma infiltration with imaging combinations: a diagnostic accuracy study.
Neuro Oncol. 2019 Sep 24. pii: noz180. doi: 10.1093/neuonc/noz180. [Epub ahead of print]
Source . Similar articles



BRAIN STEM GLIOMAS




DIFFUSE MIDLINE GLIOMAS



Jiang H, Yang K, Ren X, Cui Y, Li M, Lei Y, Lin S.
Diffuse midline glioma with an H3 K27M mutation: A comparison integrating the clinical, radiological, molecular features between adult and pediatric patients.
Neuro Oncol. 2019 Aug 24. pii: noz152. doi: 10.1093/neuonc/noz152. [Epub ahead of print]
Source . Similar articles



HIGH-GRADE GLIOMAS



Chapman CH, Hara JH, Molinaro AM, Clarke JL, Oberheim Bush NA, Taylor JW, Butowski NA, Chang SM, Fogh SE, Sneed PK, Nakamura JL, Raleigh DR, Braunstein SE.
Reirradiation of recurrent high-grade glioma and development of prognostic scores for progression and survival.
Neurooncol Pract. 2019 Sep;6(5):364-374. doi: 10.1093/nop/npz017. Epub 2019 Apr 12.
Source . Similar articles




Puranik AD, Boon M, Purandare N, Rangarajan V, Gupta T, Moiyadi A, Shetty P, Sridhar E, Agrawal A, Dev I, Shah S.
Utility of FET-PET in detecting high-grade gliomas presenting with equivocal MR imaging features.
World J Nucl Med. 2019 Jul-Sep;18(3):266-272. doi: 10.4103/wjnm.WJNM_89_18.
Source . Similar articles



GLIOMATOSIS CEREBRI



Hardian RF, Goto T, Kuwabara H, Hanaoka Y, Kobayashi S, Kanno H, Shimojo H, Horiuchi T, Hongo K.
An autopsy case of widespread brain dissemination of glioblastoma unnoticed by magnetic resonance imaging after treatment with bevacizumab.
Surg Neurol Int. 2019 Jul 5;10:137. doi: 10.25259/SNI-183-2019. eCollection 2019.
Source . Similar articles




Ordookhanian C, Amidon RF, Kaloostian PE.
Gliomatosis Cerebri: A Unique Presentation with Accompanying Clinical Nuance.
Cureus. 2019 Jul 16;11(7):e5149. doi: 10.7759/cureus.5149.
Source . Similar articles



LOW-GRADE GLIOMAS



Opoku-Darko M, Eagles ME, Cadieux M, Isaacs AM, Kelly JJP.
Natural History and Growth Patterns of Incidentally Discovered Diffusely Infiltrating Low-Grade Gliomas: A Volumetric Study.
World Neurosurg. 2019 Sep 7. pii: S1878-8750(19)32402-7. doi: 10.1016/j.wneu.2019.08.235. [Epub ahead of print]
Source . Similar articles




Pala A, Nadji-Ohl M, Faust K, Rückriegel S, Roder C, von der Brelie C, Forster MT, Löbel F, Schommer S, Löhr M, Grübel N, Rothenbacher D, König R, Engelke J, Schmitz B, Wirtz CR, Senft C, Rohde V, Tatagiba M, Ernestus RI, Vajkoczy P, Ganslandt O, Nagel G, Coburger J.
Multicentric Registry Study on Epidemiological and Biological Disease Profile as Well as Clinical Outcome in Patients with Low-Grade Gliomas: The LoG-Glio Project.
J Neurol Surg A Cent Eur Neurosurg. 2019 Sep 24. doi: 10.1055/s-0039-1693650. [Epub ahead of print]
Source . Similar articles



DIFFUSE ASTROCYTIC AND OLIGODENDROGLIAL TUMORS


Kim JH, Jang WY, Jung TY, Jung S, Kim KK, Kim HS, Kim EH, Lee MC, Moon KS, Lee KH.
Recurrent Glioma With Lineage Conversion From Oligodendroglioma to Astrocytoma in Two Cases.
Front Oncol. 2019 Aug 27;9:828. doi: 10.3389/fonc.2019.00828. eCollection 2019.
Source . Similar articles



GLIOBLASTOMA



Akimoto J, Fukami S, Suda T, Ichikawa M, Haraoka R, Kohno M, Shishido-Hara Y, Nagao T, Kuroda M.
First autopsy analysis of the efficacy of intra-operative additional photodynamic therapy for patients with glioblastoma.
Brain Tumor Pathol. 2019 Oct;36(4):144-151. doi: 10.1007/s10014-019-00351-0. Epub 2019 Sep 5.
Source . Similar articles




Alameda F, Velarde JM, Carrato C, Vidal N, Arumí M, Naranjo D, Martinez-Garcia M, Ribalta T, Balañá C.
Prognostic value of stem cell markers in glioblastoma.
Biomarkers. 2019 Nov;24(7):677-683. doi: 10.1080/1354750X.2019.1652345. Epub 2019 Sep 8.
Source . Similar articles




Bartek J Jr, Alattar AA, Dhawan S, Ma J, Koga T, Nakaji P, Dusenbery KE, Chen CC.
Receipt of brachytherapy is an independent predictor of survival in glioblastoma in the Surveillance, Epidemiology, and End Results database.
J Neurooncol. 2019 Oct;145(1):75-83. doi: 10.1007/s11060-019-03268-y. Epub 2019 Aug 30.
Source . Similar articles




Garcia CR, Villamar MF, Villano JL.
Intraventricular Glioblastoma.
Neurohospitalist. 2019 Oct;9(4):239-240. doi: 10.1177/1941874418817950. Epub 2018 Dec 30.
Source . Similar articles




Gerstner E, Emblem KE, Chang K, Vakulenko-Lagun B, Yen YF, Beers AL, Dietrich J, Plotkin SR, Catana C, Hooker JM, Duda DG, Rosen B, Kalpathy-Cramer J, Jain RK, Batchelor T.
Bevacizumab reduces permeability and concurrent temozolomide delivery in a subset of patients with recurrent glioblastoma.
Clin Cancer Res. 2019 Sep 26. pii: clincanres.1739.2019. doi: 10.1158/1078-0432.CCR-19-1739. [Epub ahead of print]
Source . Similar articles




Jaoude DA, Moore JA, Moore MB, Twumasi-Ankrah P, Ablah E, Moore DF Jr.
Glioblastoma and Increased Survival with Longer Chemotherapy Duration.
Kans J Med. 2019 Aug 21;12(3):65-69.
Source . Similar articles




Kim JY, Jackman JG, Woodring S, McSherry F, Herndon JE, Desjardins A, Friedman HS, Peters KB.
Second primary cancers in long-term survivors of glioblastoma.
Neurooncol Pract. 2019 Sep;6(5):386-391. doi: 10.1093/nop/npz001. Epub 2019 Feb 4.
Source . Similar articles




Kim N, Chang JS, Wee CW, Kim IA, Chang JH, Lee HS, Kim SH, Kang SG, Kim EH, Yoon HI, Kim JW, Hong CK, Cho J, Kim E, Kim TM, Kim YJ, Park CK, Kim JW, Kim CY, Choi SH, Kim JH, Park SH, Choe G, Lee ST, Kim IH, Suh CO.
Validation and optimization of a web-based nomogram for predicting survival of patients with newly diagnosed glioblastoma.
Strahlenther Onkol. 2019 Sep 5. doi: 10.1007/s00066-019-01512-y. [Epub ahead of print]
Source . Similar articles




Pallud J, Roux A, Mellerio C.
Glioma Resection Unmasks Eloquent Brain Areas.
World Neurosurg. 2019 Sep 11;132:251-252. doi: 10.1016/j.wneu.2019.09.012. [Epub ahead of print]
Source . Similar articles




Rodriguez J, Dionne K, Wu GF, Goyal MS, Bucelli RC.
Primary Spinal Cord Glioblastoma Multiforme in the Young and Old.
Neurohospitalist. 2019 Oct;9(4):243-244. doi: 10.1177/1941874419832443. Epub 2019 Feb 28.
Source . Similar articles




Sautter L, Hofheinz R, Tuettenberg J, Grimm M, Vajkoczy P, Groden C, Schmieder K, Hochhaus A, Wenz F, Giordano FA.
Open-Label Phase II Evaluation of Imatinib in Primary Inoperable or Incompletely Resected and Recurrent Glioblastoma.
Oncology. 2019 Sep 12:1-7. doi: 10.1159/000502483. [Epub ahead of print]
Source . Similar articles




Schneider M, Potthoff AL, Keil VC, Güresir Á, Weller J, Borger V, Hamed M, Waha A, Vatter H, Güresir E, Herrlinger U, Schuss P.
Surgery for temporal glioblastoma: lobectomy outranks oncosurgical-based gross-total resection.
J Neurooncol. 2019 Oct;145(1):143-150. doi: 10.1007/s11060-019-03281-1. Epub 2019 Sep 4.
Source . Similar articles




Shieh LT, Guo HR, Chang YK, Lu NM, Ho SY.
Clinical implications of multiple glioblastomas: An analysis of prognostic factors and survival to distinguish from their single counterparts.
J Formos Med Assoc. 2019 Sep 10. pii: S0929-6646(19)30251-7. doi: 10.1016/j.jfma.2019.08.024. [Epub ahead of print]
Source . Similar articles




Swinnen J, Gelin G, Fransis S, Vandevenne J, Van Cauter S.
Glioblastoma with extracranial parotid, lymph node, and pulmonary metastases: a case report.
Radiol Case Rep. 2019 Sep 5;14(11):1334-1347. doi: 10.1016/j.radcr.2019.08.011.
Source . Similar articles



*

Wang J, Liu J, Sun G, Meng H, Wang J, Guan Y, Yin Y, Zhao Z, Dong X, Yin S, Li H, Cheng Y, Wu H, Wu A, Yu X, Chen L.
Glioblastoma extracellular vesicles induce the tumour-promoting transformation of neural stem cells.
Cancer Lett. 2019 Sep 12;466:1-12. doi: 10.1016/j.canlet.2019.09.004. [Epub ahead of print]
Source . Similar articles




Weller J, Tzaridis T, Mack F, Steinbach JP, Schlegel U, Hau P, Krex D, Grauer O, Goldbrunner R, Bähr O, Uhl M, Seidel C, Tabatabai G, Brehmer S, Bullinger L, Galldiks N, Schaub C, Kebir S, Stummer W, Simon M, Fimmers R, Coch C, Glas M, Herrlinger U, Schäfer N.
Health-related quality of life and neurocognitive functioning with lomustine-temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial.
Lancet Oncol. 2019 Oct;20(10):1444-1453. doi: 10.1016/S1470-2045(19)30502-9. Epub 2019 Sep 2.
Source . Similar articles




Xue Y, Cooper G, Cai C, Lu S, Hu B, Ma X, Lu X.
Tumour-specific Causal Inference Discovers Distinct Disease Mechanisms Underlying Cancer Subtypes.
Sci Rep. 2019 Sep 13;9(1):13225. doi: 10.1038/s41598-019-48318-7.
Source . Similar articles



EMBRYONAL TUMORS



MEDULLOBLASTOMA



Bleil CB, Bizzi JWJ, Bedin A, de Oliveira FH, Antunes ÁCM.
Survival and prognostic factors in childhood medulloblastoma: A Brazilian single center experience from 1995 to 2016.
Surg Neurol Int. 2019 Jun 25;10:120. doi: 10.25259/SNI-237-2019. eCollection 2019.
Source . Similar articles




Narayan V, Sugur H, Jaiswal J, Arvinda HR, Arivazhagan A, Somanna S, Santosh V.
Medulloblastoma: Distinctive Histo-Molecular Correlation with Clinical Profile, Radiologic Characteristics, and Surgical Outcome.
Pediatr Neurosurg. 2019 Sep 3:1-12. doi: 10.1159/000501913. [Epub ahead of print]
Source . Similar articles



METASTATIC TUMORS


Miki K, Yoshimoto K, Yamada Y, Kabashima A, Kuga D, Oda Y, Iihara K.
Rapid growth of metastatic brain tumor from gastric undifferentiated pleomorphic sarcoma: A case report.
Surg Neurol Int. 2019 Apr 24;10:74. doi: 10.25259/SNI-84-2019. eCollection 2019.
Source . Similar articles




Takahara K, Mochizuki Y, Ichimura S, Kurebayashi Y, Fujii K.
Brain metastasis from urachal carcinoma.
Surg Neurol Int. 2019 Aug 2;10:152. doi: 10.25259/SNI_79_2019. eCollection 2019.
Source . Similar articles



bottom